DASATRUE 70MG 60 TABLETS (IP)

Form: Tablet

Pack Size: 60 Tablets

Marketed by: CIPLA LTD (CANCER CARE)

MRP: ₹8765.62

Dasatrue 70mg by Cipla (dasatinib 70 mg, 60 tablets) is a BCR-ABL tyrosine kinase inhibitor listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by haemato-oncologists for Philadelphia chromosome-positive chronic myeloid leukaemia (including when imatinib has stopped working) and Philadelphia chromosome-positive acute lymphoblastic leukaemia. Schedule H: dispense only against a valid prescription. Counselling point: watch for pleural effusion (breathlessness) and low blood counts.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.